During an open public hearing before the vote, the panel heard from multiple speakers, including public health advocates, physicians, and peptide companies, who expressed widely differing views on whether BPC-157 should be included on the 503A bulk drug list
People with Wilson's disease are an exception because their regulatory mechanisms are impaired, which is why they should avoid supplemental copper
Prefer treatments researched in human fertility populations
In chronic wounds, a 2021 RCT (n=72 diabetic ulcers) reported 85% closure rate with GHK-Cu dressings at 12 weeks versus 55% control (OR 4.2
Build your own bag
Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
